Tigermed HK$10.7 billion IPO and Hong Kong listing
Davis Polk advised Hangzhou Tigermed Consulting Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Innovent Biologics HK$4.65 billion share placement
Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…
Ocumension Therapeutics HK$1.55 billion IPO and HKEX listing
Davis Polk advised the underwriters in the initial public offering of Ocumension Therapeutics on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule…
Shenzhen Hepalink Pharmaceutical Group HK$4.05 billion IPO
Davis Polk advised Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering…
Ronshine China Holdings $250 million high-yield notes offering
Davis Polk advised the initial purchasers on the Regulation S offering of high-yield notes by Ronshine China Holdings Limited of $250 million principal amount of 7.350% senior notes due…
NetEase HK$20.9 billion secondary listing and IPO on HKEX
Davis Polk advised the underwriters in the secondary listing and initial public offering of NetEase, Inc. on the Hong Kong Stock Exchange. The gross proceeds from the global offering…
Legend Biotech $487 million IPO
Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…
Shandong Hi-Speed Group $2 billion MTN program and $800 million drawdown
Davis Polk advised the arrangers in connection with the establishment of the $2 billion medium-term note program of Coastal Emerald Limited, which is an indirectly wholly owned subsidiary…
Beijing Hongkun $55 million high-yield notes offering
Davis Polk advised Hongkong Ideal Investment Limited Beijing (the “Issuer”) on its $55 million Regulation S offering of 14.750% guaranteed senior notes due 2022, to be consolidated and form…
Xi’an Aerospace High-Tech Industry Development $200 million bond offering
Davis Polk advised the joint lead managers on a Regulation S offering by Xi’an Aerospace High-Tech Industry Development Co., Ltd, a company incorporated in the People’s Republic of China…